Clinical trial
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09, a Long-acting Glucagon-like Peptide-1 Mimetic, in Healthy Subjects
NCT04354090 is registered in ClinicalTrials.gov with Beijing Dongfang Biotech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09, a Long-acting Glucagon-like Peptide-1 Mimetic, in Healthy Subjects
- Lead sponsor
- Beijing Dongfang Biotech Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 26, 2018
- Completion date
- June 22, 2019
- Enrollment
- 41 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.